Cargando…
Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. A substantial proportion of patients with PCOS are either overweight or obese, and excess body weight aggravates the hormonal, reproductive and metabolic manifestations of PCOS. In recent years, several stu...
Autores principales: | Kourtidou, Christodoula, Tziomalos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953739/ https://www.ncbi.nlm.nih.gov/pubmed/36831032 http://dx.doi.org/10.3390/biomedicines11020496 |
Ejemplares similares
-
The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2023) -
Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review
por: Kourtidou, Christodoula, et al.
Publicado: (2023) -
Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018) -
Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2021) -
Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)